News Release Details
Launches new digital tool for pain management
ComfortAble uses proven cognitive behavioral therapy techniques to help users identify and change unhelpful thinking and behavior patterns and learn new problem-solving techniques. It features clinical vignettes, interactive multimedia activities and exercises that facilitate the development of new skills. Users can track their progress through each session. Upon completion, new resources and activities are assigned.
The tool enhances one part of Magellan’s broad-based digital strategy: the Virtual Care Solution (VCS), an innovative platform and portal that includes a collection of digital and digitally enabled telehealth programs that help identify and support those with medical and behavioral health conditions. Magellan’s software suite includes apps for mood (MoodCalmer), anxiety, panic, and phobia (FearFighterTM), sleep difficulty and insomnia (RESTORETM), and web-based modules for substance and alcohol misuse (SHADE) and obsessive-compulsive disorder (OCFighter).
The VCS platform enhances the delivery of services to underserved areas and to individuals who may find it challenging to find time to see a provider in-person. The modules are available in both English and Spanish, are designed to be culturally sensitive, support a range of literacy needs and can be accessed on most mobile devices. At any given time, over 2,000 people are actively using Magellan’s VCS and engaging in our digital programs.
ComfortAble, along with Magellan’s Restore, FearFighter and MoodCalmer DCBT modules, is offered as a smartphone app for members of Magellan client health plans. These modules are available on the
“With the launch of ComfortAble, Magellan maintains our market differentiation as the only organization to offer the most robust suite of DCBT programs that expands access to evidence-based care, addresses complex conditions and improves the health of our members,” said
Magellan’s DCBT modules address the needs of those with complex conditions and have undergone numerous clinical trials in which they have matched, and in some instances exceeded, those reached by conventionally delivered cognitive behavioral therapy.